Clinical Trial Update: Rosuvastatin ORBITAL Germany [Phase 3]

View source ↗

Summary

This update indicates the Phase 3 Rosuvastatin ORBITAL trial in Germany has completed, evaluating rosuvastatin for hypercholesterolemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Rosuvastatin (Crestor) (rosuvastatin)

Snippet

Sponsor: AstraZeneca | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED